Neurological Disorders and Treatments

When neurons are damaged by events like ischemic stroke or the slow cellular deterioration seen in Alzheimer's disease and glaucoma, the brain's limited capacity for self-repair makes treatment both urgent and difficult. A central focus of current neurology research is understanding how oxidative stress and mitochondrial dysfunction drive that damage, and whether compounds like Citicoline and Cerebrolysin can meaningfully interrupt those processes to protect or restore neural tissue. Both agents have shown biological activity across several injury models, yet researchers continue to work out precisely how they act at the cellular level and whether their effects translate reliably into clinical benefit. Key open questions include how neuroprotective therapies should be timed relative to injury, how they might be combined for greater effect, and which patients are most likely to respond.

Works

90,856

Total citations

298,991

Keywords

CiticolineCerebrolysinOxidative StressIschemic StrokeNeuroprotectionMitochondrial Dysfunction